Burning Rock Biotech (BNR) Stock Price, Quote, News & History

Burning Rock Biotech Ltd (BNR) Stock Price, Quote, News & History

BNRNASDAQ

Trade with Public

$23.46

0.984.36%

At close: Mar 9, 5:00 PM EST

$24.60

2.129.43%

Pre-Market: 7:00 AM EST

Key Statistics

Open

$23.46

Volume / Avg.

0 / 32.97K

Day Range

- - -

52 Wk Range

2.18 - 41.72

Market Cap

$252.36M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.04%

Days to Cover

5.72

Recent Burning Rock Biotech Ltd News

Michael Saylor, Nayib Bukele, Tom Lee Stand Firm Amid Crypto Sell-Off — Here Are Entities Buying Bitcoin, Ethereum Dips Aggressively

While sentiment has soured due to the ongoing sell-off in the cryptocurrency market, several notable investors have continued to accumulate Bitcoin (CRYPTO: BTC) and <

Aniket Verma

Burning Rock Stock Up 35%+ As Loss Narrows

Bamboo Works

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-32.42M

Investing Cash Flow (TTM)

-4.88M

Financing Cash Flow (TTM)

1.93M

Free Cash Flow (TTM)

-38.40M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-35.38M

Valuation Metrics

Enterprise Value

$190.36M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

3.20

PB Ratio (TTM)

3.17

Earnings Yield % (TTM)

-7.17%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$7.40

Company Debt

Total Debt

$2.00M

LT Debt

$1.80M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$463.99M

Debt to Equity

0.06

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$23.46

Volume / Avg.

0 / 32.97K

Day Range

- - -

52 Wk Range

2.18 - 41.72

Market Cap

$252.36M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.04%

Days to Cover

5.72

About

Sector

Health Care

Industry

Biotechnology

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Burning Rock Biotech (BNR) stock?

You can purchase shares of Burning Rock Biotech (NASDAQ:BNR) through any online brokerage.

View our list of the best stock brokerages

Who are Burning Rock Biotech (BNR) competitors?

Other companies in Burning Rock Biotech’s space includes: Macrogenics Inc (NASDAQ:MGNX), Humacyte Inc (NASDAQ:HUMA), Atrium Therapeutics Inc (NASDAQ:RNA), Voyager Therapeutics Inc (NASDAQ:VYGR) and Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL).

What is the forecast, or price target, for Burning Rock Biotech (BNR) stock?

There is no analysis for Burning Rock Biotech to provide a consensus price target.

What is the current price for Burning Rock Biotech (BNR)?

The stock price for Burning Rock Biotech (NASDAQ: BNR) is $24.6 last updated February 26, 2026 at 8:10 AM EST.

Does Burning Rock Biotech (BNR) pay a dividend?

There are no upcoming dividends for Burning Rock Biotech.

When is Burning Rock Biotech (NASDAQ:BNR) reporting earnings?

Burning Rock Biotech does not have any upcoming earnings scheduled.

Is Burning Rock Biotech (BNR) going to split?

There is no upcoming split for Burning Rock Biotech.

What sector and industry does Burning Rock Biotech (BNR) operate in?

Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Atrium Therapeutics Inc

NASDAQ:RNA

$14.84

1.15%

Voyager Therapeutics Inc

NASDAQ:VYGR

$5.20

3.85%

Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL

$3.08

0.65%

Elicio Therapeutics Inc

NASDAQ:ELTX

$12.90

Eledon Pharmaceuticals Inc

Key Statistics

Open

$23.46

Volume / Avg.

0 / 32.97K

Day Range

- - -

52 Wk Range

2.18 - 41.72

Market Cap

$252.36M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.04%

Days to Cover

5.72

Recent Burning Rock Biotech Ltd News

Michael Saylor, Nayib Bukele, Tom Lee Stand Firm Amid Crypto Sell-Off — Here Are Entities Buying Bitcoin, Ethereum Dips Aggressively

While sentiment has soured due to the ongoing sell-off in the cryptocurrency market, several notable investors have continued to accumulate Bitcoin (CRYPTO: BTC) and <

Aniket Verma

Burning Rock Stock Up 35%+ As Loss Narrows

Bamboo Works

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-32.42M

Investing Cash Flow (TTM)

-4.88M

Financing Cash Flow (TTM)

1.93M

Free Cash Flow (TTM)

-38.40M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-35.38M

Valuation Metrics

Enterprise Value

$190.36M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

3.20

PB Ratio (TTM)

3.17

Earnings Yield % (TTM)

-7.17%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$7.40

Company Debt

Total Debt

$2.00M

LT Debt

$1.80M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$463.99M

Debt to Equity

0.06

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$23.46

Volume / Avg.

0 / 32.97K

Day Range

- - -

52 Wk Range

2.18 - 41.72

Market Cap

$252.36M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.04%

Days to Cover

5.72

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry